TWD 60.7
(-2.72%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 118.39 Million TWD | 10.25% |
2022 | 107.39 Million TWD | 46.67% |
2021 | 73.21 Million TWD | -6.02% |
2020 | 77.9 Million TWD | 31.92% |
2019 | 59.05 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 127.78 Million TWD | 7.93% |
2024 Q2 | 175.7 Million TWD | 37.5% |
2023 Q4 | 118.39 Million TWD | 53.98% |
2023 Q3 | 76.88 Million TWD | 8.47% |
2023 FY | 118.39 Million TWD | 10.25% |
2023 Q2 | 70.88 Million TWD | 17.58% |
2023 Q1 | 60.28 Million TWD | 0.0% |
2022 Q4 | - TWD | 0.0% |
2022 FY | 107.39 Million TWD | 46.67% |
2021 FY | 73.21 Million TWD | -6.02% |
2020 FY | 77.9 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 80.316% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 23.829% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -180.75% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 89.197% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 92.592% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 89.196% |
Center Laboratories, Inc. | 269.22 Million TWD | 56.024% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -56.202% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 49.398% |
InnoPharmax Inc. | 22.24 Million TWD | -432.28% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 14.705% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 45.511% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -22.67% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | 6.628% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -309.049% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 58.291% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -2.297% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -1075.253% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -111.609% |